GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,853 | -43.4% | 3,919 | -17.9% | 0.00% | – |
Q2 2023 | $26,244 | +28.1% | 4,776 | 0.0% | 0.00% | – |
Q1 2023 | $20,489 | -74.5% | 4,776 | -76.6% | 0.00% | – |
Q4 2022 | $80,357 | -19.6% | 20,447 | +7.8% | 0.00% | – |
Q3 2022 | $100,000 | -11.5% | 18,969 | +10.5% | 0.00% | – |
Q2 2022 | $113,000 | -8.1% | 17,164 | +2.8% | 0.00% | – |
Q1 2022 | $123,000 | +5.1% | 16,689 | +1.0% | 0.00% | – |
Q4 2021 | $117,000 | -71.7% | 16,522 | 0.0% | 0.00% | – |
Q3 2021 | $414,000 | +63.0% | 16,522 | +75.3% | 0.00% | – |
Q2 2021 | $254,000 | -1.2% | 9,427 | +4.1% | 0.00% | – |
Q1 2021 | $257,000 | +394.2% | 9,056 | +397.9% | 0.00% | – |
Q4 2020 | $52,000 | +23.8% | 1,819 | +33.2% | 0.00% | – |
Q3 2020 | $42,000 | -88.4% | 1,366 | -92.1% | 0.00% | – |
Q2 2020 | $362,000 | – | 17,339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |